Company / PP&E per Share
TG Therapeutics, Inc. PP&E per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
-69.7%
vs FY2022
Sector context
#188 of 191
Health Care
What the data says
Among 191 Health Care companies, TG Therapeutics, Inc. is in the bottom 2% for pp&e per share. PP&E per Share has declined for 3 consecutive years, from $0.00 in FY2020 to $0.00 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -28.3%.
Declined from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -47.2%
- 5-Year CAGR
- -28.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2023, pp&e per share decreased 69.7% year-over-year.
- Ranks #188 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -69.7% |
| FY2022 | $0.00 | -49.8% |
| FY2021 | $0.00 | -2.9% |
| FY2020 | $0.00 | +30.8% |
| FY2019 | $0.00 | -2.0% |
| FY2018 | $0.00 | -14.1% |
| FY2017 | $0.00 | -40.3% |
| FY2016 | $0.01 | +548.2% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026